Core Insights - Acentra Health has appointed Balajee Sethuraman as Executive Vice President and Chief Business Services Officer to enhance its business services and delivery operations [1][2] Group 1: Leadership Appointment - Balajee Sethuraman is recognized as a transformative leader with nearly 30 years of experience in healthcare and technology sectors [2][3] - His previous role was as President & Managing Partner at Emids, where he focused on growth in digital health [3] Group 2: Strategic Goals - The appointment supports Acentra Health's strategy to streamline operations through a unified operating model [1] - Sethuraman aims to advance AI technologies and improve client services, emphasizing disciplined execution and quality standards [4] Group 3: Company Overview - Acentra Health combines public sector knowledge, clinical expertise, and technology to modernize healthcare experiences for various partners [5] - The company is backed by Carlyle, a global investment firm, indicating strong financial support [5]

Among giant private capital firms, Carlyle is playing catch up. Chief Harvey Schwartz insists there is plenty of growth left in the frothy $2 trillion private credit business. https://t.co/v34UOZWIEJ (Photo: Steven Ferdman via Getty Images) https://t.co/43xFxAAYkB ...

Core Viewpoint - Carlyle Credit Income Fund (CCIF) is set to release its financial results for the first quarter of 2026 on February 25, 2026, followed by a conference call on February 26, 2026, to discuss these results [1]. Company Overview - Carlyle Credit Income Fund (NYSE: CCIF) is an externally managed closed-end fund that primarily invests in equity and junior debt tranches of collateralized loan obligations (CLOs) [3]. - The CLOs are backed by a portfolio mainly consisting of U.S. senior secured loans from a diverse range of underlying borrowers across various industry sectors [3]. - CCIF is managed by Carlyle Global Credit Investment Management L.L.C. (CGCIM), which is a wholly owned subsidiary of Carlyle and is registered with the SEC [3]. Carlyle Group Overview - Carlyle (NASDAQ: CG) is a global investment firm that manages $474 billion in assets as of September 30, 2025, and operates across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest [4]. - The firm employs over 2,400 people across 27 offices worldwide [4].

Core Insights - Eldridge and Carlyle AlpInvest have successfully closed the Eldridge Diversified Credit Fund I, which is expected to provide up to approximately $1.5 billion in investable capital through equity commitments and debt financing [1][2][3] Group 1: Fund Overview - EDCF I was established through a credit secondary solution, anchored by the purchase of a diversified portfolio of loans and leases from Eldridge and its affiliates [2] - The Fund's capital base includes commitments from leading institutional investors globally, reflecting strong market interest [2] Group 2: Strategic Goals and Partnerships - The goal of the Fund is to meet the evolving needs of institutional borrowers while generating attractive returns through a differentiated, multi-strategy credit platform [3] - Eldridge's diversified credit platform combines corporate credit capabilities with asset-based equipment origination, providing a flexible toolkit for market navigation [3] Group 3: Financial and Legal Advisory - BNP Paribas arranged and led a senior credit facility to support EDCF I, indicating strong financial backing [3] - PJT Partners served as lead financial adviser, with Jefferies as co-lead, while Kirkland & Ellis LLP and Ropes & Gray LLP acted as legal counsel for Eldridge and Carlyle AlpInvest respectively [4] Group 4: Company Profiles - Eldridge is an asset management and insurance holding company with over $70 billion in assets under management, focusing on diversified credit, GP solutions, real estate credit, and sports & entertainment [5] - Carlyle AlpInvest is a leading global private equity investor with $102 billion in assets under management and over 700 investors, having committed over $111 billion across various investment strategies [6]

Core Insights - Centerra Gold Inc. has announced an updated mineral resource and a Preliminary Economic Assessment (PEA) for its Kemess project, indicating strong economic potential with an after-tax NPV5% of $1.1 billion and an IRR of 16% based on long-term metal prices of $3,000 per ounce of gold and $4.50 per pound of copper [3][4][36]. Mineral Resource and Economic Highlights - The updated mineral resource includes 3.3 million ounces of gold and 1.1 billion pounds of copper in the indicated category, and 3.6 million ounces of gold and 1.2 billion pounds of copper in the inferred category [7][23]. - The PEA outlines a 15-year mine life with average annual production of 171,000 ounces of gold and 61 million pounds of copper, at an all-in sustaining cost (AISC) of $971 per ounce [4][10][36]. - At spot prices of $4,500 per ounce of gold and $6.00 per pound of copper, the after-tax NPV5% increases to $2.8 billion, with an IRR of 29% [7][36]. Project Execution Strategy - The project will utilize an integrated mining strategy, starting with open pit operations followed by underground mining approximately two years later, optimizing the use of existing infrastructure [4][10][36]. - Initial non-sustaining capital expenditures are estimated at $771 million, with an additional $277 million planned for expansionary capital to support underground operations [17][18]. Exploration Potential - Significant exploration upside exists, with 28 kilometers of drilling completed in 2025, confirming mineralization continuity and identifying further resource growth opportunities [27][28]. - Future exploration will focus on infill drilling at the Kemess Main zone and resource extension at the Kemess Offset zone, with potential targets identified along the eastern extensions [28][29]. Community and Economic Impact - The Kemess project is expected to create over 700 jobs and generate substantial economic benefits for local communities and First Nations, reinforcing its role as a significant economic driver in British Columbia [34][32].

Core Insights - Acentra Health has appointed Deborah Ricci as Executive Vice President and Chief Financial Officer, aiming to enhance its financial leadership during a critical phase of growth and transformation [1][3]. Company Overview - Acentra Health is a technology and health solutions company focused on improving health outcomes for government and commercial clients, leveraging public sector knowledge, clinical expertise, and technological innovation [5]. - The company is backed by Carlyle, a global investment firm, indicating strong financial support and potential for growth [5]. Leadership Background - Deborah Ricci joins Acentra Health from Guidehouse Inc., where she served as Partner and Chief Financial & Administrative Officer, overseeing finance, accounting, quality, risk, security, and facilities [2]. - Ricci has extensive experience in senior finance leadership roles, including CFO positions at Constellis, Centerra Group, and A-T Solutions, and began her career as a certified public accountant with KPMG [2]. Strategic Vision - The CEO of Acentra Health, Todd Stottlemyer, emphasized Ricci's proven track record in building scalable financial systems and leading organizations through significant changes, aligning her expertise with the company's growth and transformation plans [3]. - Ricci expressed her commitment to Acentra Health's mission-driven work and long-term value creation, indicating a strong alignment with the company's strategic goals [4]. Additional Roles - Ricci currently serves as Chair of the Finance and Audit Committee for Draken International Inc. and is an advisory board member for Cydecor, showcasing her active involvement in the finance sector [4]. - She holds an MBA from the University of Pittsburgh School of Business and a bachelor's degree from Bentley University, highlighting her strong educational background [4].

Summary of Fortitude Re's Conference Call Company Overview - **Company**: Fortitude Re, a leading asset-intensive reinsurer, provides tailored reinsurance solutions and is supported by major investors including T&D Holdings and Carlyle [2][3] - **Financial Metrics**: As of September 30, 2025, Fortitude Re has a balance sheet exceeding $100 billion, with $6.9 billion in capital from investors and over $75 billion in general account reserves [3][4] Key Financial Performance - **Growth**: Achieved $83 billion in general account reserves, with core operating earnings of $674 million and adjusted net income of $669 million for the nine months ended September 30, 2025 [7][8] - **Market Share**: Holds over 25% market share in Japan and approximately 10% in North America since 2020 [4][6] - **Earnings Stability**: Core return on assets remains consistent, with a strong liquidity profile of approximately $5.3 billion [8][9] Strategic Initiatives - **Reinsurance Transactions**: Completed several block and flow reinsurance transactions adding nearly $10 billion in high-quality reserves [5] - **Capital Market Presence**: Issued senior notes and launched the first sidecar, FCA Re, with over $700 million in capital dedicated to Asia [5][6] - **Risk Management**: Emphasizes a robust risk management culture, with a focus on diversification, liability valuation, and asset-liability management [10][11] Investment Portfolio - **Asset Allocation**: The $82 billion investment portfolio is primarily fixed income (93%), with only 4% rated below investment grade [24] - **Private Credit**: $17.3 billion in private credit, primarily investment grade, with strong credit performance and no material losses [25][26] - **Real Estate Exposure**: $13.6 billion in real estate, with a focus on residential mortgages and a low average loan-to-value (LTV) ratio [26][27] Market Dynamics and Competitive Position - **Market Segments**: Operates in three of six key market segments, with a focus on complex transactions that yield above-market returns [30][31] - **Competitive Strength**: Maintains a competitive edge through disciplined underwriting, strong investor relationships, and a focus on sticky liabilities [32][39] - **Regulatory Environment**: Anticipates convergence of global regulatory regimes, which may benefit Fortitude's business model [44][45] Risks and Challenges - **Credit Stress**: Identified as a primary risk, with concerns over potential defaults and losses in the current geopolitical climate [59][60] - **Market Volatility**: Acknowledges the potential for market disruptions affecting credit quality, but expresses confidence in the company's resilience due to robust risk management practices [60][61] Future Outlook - **Growth Prospects**: Optimistic about future profitability and pipeline quality, with expectations for healthy growth in core operating earnings and adjusted net income in 2026 [51][56] - **Strategic Focus**: Plans to continue responsible growth by selectively underwriting in existing markets while expanding into new ones [37][38] This summary encapsulates the key points discussed during the conference call, highlighting Fortitude Re's financial performance, strategic initiatives, market dynamics, and future outlook.

Group 1 - Carlyle, Chevron, Quantum Capital Group, and International Holding Company are competing for global assets of Russia [1] - The competition highlights the interest of private equity firms and major oil companies in acquiring valuable assets in the current geopolitical climate [1] - The involvement of UAE-based investors indicates a growing trend of Middle Eastern capital seeking opportunities in global markets [1] Group 2 - The strategic moves by these companies may reshape the investment landscape in the energy sector [1] - The competition for Russian assets reflects broader trends in private equity and energy investments amid ongoing global economic shifts [1] - The outcome of this competition could have significant implications for future investment strategies in the region [1]

Core Insights - Acentra Health has been recognized among Modern Healthcare's 2025 Best in Business in the Healthcare IT category, highlighting its role in driving innovation and excellence in the healthcare industry [1][3] Company Achievements - Acentra Health's Medicaid Enterprise System (MES) solution was the first to receive the Centers for Medicare & Medicaid's Streamlined Claims Module Certification and is highly ranked in NASPO ValuePoint™ categories [2] - The company has successfully reduced hospitalizations, emergency department visits, and assessment turnaround times through its care management programs [2] - Acentra Health has achieved a 12% reduction in Medicaid costs and a 20% increase in primary care use in Oregon, supporting nearly 3,000 individuals through its housing and rent assistance program [7] Industry Impact - Acentra Health serves beneficiaries in all 50 states, improving access to healthcare for over 170 million people [3] - The company is recognized for its innovative approaches that redefine care delivery and operations, contributing to the overall progress in the healthcare ecosystem [3]

Core Viewpoint - XA Investments LLC has launched the XAI Interval Fund Credit Index™ (INTVL-C) to track the performance of non-listed closed-end interval funds and tender offer funds focused on alternative credit investments [1][5]. Group 1: Index Overview - INTVL-C is designed to provide fair performance comparisons among interval funds with similar investment profiles and operational constraints, calculated daily on a total return basis [2][5]. - As of December 31, 2025, the Index's 58 constituents combined for over $79 billion in total net assets, with a base date of January 1, 2023 [2][5]. Group 2: Industry Significance - The launch of INTVL-C is considered a significant advancement for the alternative credit fund landscape, providing asset managers with a transparent view for benchmarking and peer comparison [5]. - INTVL-C is the only available credit index focusing on credit interval and tender offer funds, underscoring XA Investments' commitment to innovative research in this market [3][5]. Group 3: Constituents and Performance - The Index includes leading funds from managers such as Cliffwater, CION, Carlyle, PIMCO, Lord Abbett, Variant, Stone Ridge, Apollo, and Federated Hermes, capturing primary drivers of performance within the segment [4][5]. - The broader XAI Interval Fund Index tracks all interval and tender offer funds with over $100 million in net assets, comprising 101 constituents across seven asset classes [5].